H.R. 7970 · 119th Congress · Crime and Law Enforcement
STOP Nitazenes Act
Permanently places nitazenes in schedule I of the Controlled Substances Act. AI-read
- IntroducedMar 18, 2026 Done
- CommitteeReferred to 2 committees Current stage
- House floorNot yet Not reached yet
- Senate floorNot yet Not reached yet
- Chambers agreeNot yet Not reached yet
- PresidentNot yet Not reached yet
What it does
This bill permanently places nitazenes as a class into schedule I of the Controlled Substances Act. Nitazenes are synthetic opioids similar to fentanyl that can be as potent or more potent than fentanyl. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.
Congressional Research Service · summary of “Introduced in House” version · Mar 18, 2026
Who lobbies on it
1 organization · 1 filing · Q1 2026–Q3 2026One square per quarter since introduction, oldest left. Filled = named it that quarter.
-
American Medical Association
1 of 3 quarters
“H.R.1266 - Combating Illicit Xylazine Act, all provisions H.R.1561 - ALERT Communities Act, all provisions H.R.2004 - Tylers Law, all provisions H.R.7970 - STOP Nitazenes Act, all provisions H.R.7994 - HERO Act, all provisions Comment Letter: [2026-11602] HHS Request for Comment on Chronic Disease of Addiction Chronic…”
$17.6M lobbying spend in 2026 to date, all issuesQ2 2026 filing
Organizations that named H.R. 7970 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. “Gave to” means the organization’s PAC gave to the member’s campaign in the 2025–26 cycle, net of refunds; it doesn’t mean the money was about this bill. Organizations may lobby for, against, or to change a bill; filings don’t say which. Source: Senate lobbying disclosures (LD-2) from lda.gov; PAC gifts from FEC filings; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.
Actions
8 actions · newest first- Jul 21, 2026Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 28 - 21.
- Jul 21, 2026Committee Consideration and Mark-up Session Held
- Jul 20, 2026Committee Consideration and Mark-up Session Held
- Jun 25, 2026Forwarded by Subcommittee to Full Committee by Voice Vote.
Show all 8 actionsShow fewer
- Jun 25, 2026Subcommittee Consideration and Mark-up Session Held
- Mar 18, 2026Referred to the Subcommittee on Health.
- Mar 18, 2026Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Mar 18, 2026Introduced in House